Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Development of a breakthrough gene therapy for the treatment of ALS – EIC Pathfinder Planning Project
| Reference number | 2025-03704 |
| Coordinator | Axial Cell Systems AB |
| Funding from Vinnova | SEK 384 409 |
| Project duration | November 2025 - May 2026 |
| Status | Ongoing |
| Venture | Global cooperation 2025 |
| Call | Planning grant for international proposal 2025 |
Last updated 10 October 2025
Reference number 2025-03704
